Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes

CXA-101, a novel oxyimino-aminothiazolyl cephalosporin, CXA-201 (CXA-101 combined with tazobactam), and various comparators were susceptibility tested by broth microdilution methods against 1,301 well-characterized clinical strains collected worldwide, including ceftazidime-resistant members of the...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sader, Helio S., Rhomberg, Paul R., Farrell, David J., Jones, Ronald N.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2011
Предметы:
Susceptibility
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3088243/
https://ncbi.nlm.nih.gov/pubmed/21321149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01737-10
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы